Regentis Biomaterials Ltd. (RGNT) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Regentis Biomaterials Ltd. (RGNT) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $7.7M, listed on AMEX, employing roughly 10 people, carrying a beta of 1.42 to the broader market. Regentis Biomaterials Ltd. Led by Ehud Geller, public since 2025-09-11.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for RGNT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →